HHMI To Award $90 Million To Medical Schools

October 14, 1998

CHEVY CHASE, Md., October 15, 1998—The Howard Hughes Medical Institute (HHMI) plans to award $90 million in four-year grants to help selected medical schools sustain their critical biomedical research activities amid major changes in the U.S. health care system.

The grants will range from $2.5 million to $4 million, with the first payment in September 1999. They build on a similar series of grants totaling $80 million that HHMI awarded to 30 medical schools in 1995.

The Institute has sent invitations to all of the nation's 125 medical schools to submit proposals for the new grants competition. A panel of distinguished biomedical scientists and scientific administrators will evaluate the proposals, which are due by January 14, 1999. The Institute's Trustees will authorize funding based on the final recommendations of HHMI management.

"Medical schools have contributed to many of our greatest medical advances, but they are now having great difficulty supporting their research infrastructure and meeting the full costs of biomedical research," said Purnell W. Choppin, HHMI's president. "Changes in the health care system, particularly the growth of managed care and new federal cost-containment policies, have placed great stress on the systems that have allowed medical research to thrive. We are awarding these grants to help medical schools continue the revolutionary advances in knowledge of biological processes and disease mechanisms and the application of that knowledge to the prevention and cure of diseases."

HHMI's initiative will provide medical schools with resources to conduct basic, disease-oriented and patient-oriented research. Each medical school that applies will be asked to determine its own priorities and needs. HHMI anticipates that many of the proposals will address needs such as junior faculty start-up, core facilities, major equipment, updating of research laboratories and pilot research projects.

The 30 medical schools that received the 1995 grants allocated more than half of the money to faculty start-up. Once again, HHMI seeks to assist junior faculty in establishing independent laboratories. Noting that "the pool of physician-scientists who perform disease- and patient-oriented research has failed to grow commensurately with the pool of basic research scientists," the new program announcement also emphasizes the importance of assisting scientists who combine the insights of treating patients with expertise in the research laboratory.

As in 1995, a significant share of the grants budgets may also be used for core facilities and equipment, such as transgenic and other animal care facilities, facilities for maintenance of biological stocks, imaging centers, computer services and other resources. The new competition once again provides medical schools with considerable flexibility in meeting their needs.

"These grants will enhance the scientific programs of both basic science and clinical departments, across the spectrum from basic to patient-oriented research," said Joseph G. Perpich, HHMI's vice president for grants and special programs. "Our goal is to foster collaborations that yield important new insights into disease mechanisms and stimulate the development of new medical interventions."

The grants are being awarded through HHMI's Research Resources program, which also provides major support to unique national research resources, such as Jackson Laboratory's transgenic mouse resource program. Additional information about the program is available at: http://www.hhmi.org/grants/research_resources/.

The Howard Hughes Medical Institute is a medical research organization whose principal purpose is the conduct of biomedical research. It employs scientists in cell biology, genetics, immunology, neuroscience and structural biology. More than 330 Hughes investigators conduct medical research in HHMI laboratories at 72 outstanding academic medical centers and universities nationwide. Through its complementary grants program, HHMI supports science education in the United States and a select group of researchers abroad.
-end-


Howard Hughes Medical Institute

Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.